Martin Heidecker
InvestorChief Investment Officer at AMR Action Fund
FoundedAbexxa BiologicsElion TherapeuticsRgenta TherapeuticsVedanta Biosciences
About
Joined the fund in 2021 with extensive venture capital and drug development experience. Previously Managing Director USA of Boehringer Ingelheim Venture Fund and began his investing career at Bayern Kapital in Germany.
Deals · 4
Vedanta BiosciencesBoard seat
via AMR Action Fund · filed Aug 2024 · $118.5M raise
Adaptive Phage TherapeuticsBoard seat
via AMR Action Fund · filed Jun 2023 · $30M raise
Rgenta TherapeuticsBoard seat
via AMR Action Fund · filed Mar 2021 · $38M raise
Abexxa BiologicsBoard seat
via AMR Action Fund · filed Sep 2016 · $1.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at AMR Action Fund
Bill Burns
Board Chair at AMR Action Fund
Carly Levine
Senior Associate at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund